Grace Therapeutics Files Prospectus For Offering 4.762M Common Shares On Behalf Of Selling Shareholders

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

https://www.sec.gov/Archives/edgar/data/1444192/000114036126034189/ny20080485x1_s3.htm

Comments

No comments yet. Be the first!